These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 29551286)
21. MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes. Zou Y; Li S; Li Z; Song D; Zhang S; Yao Q Cell Signal; 2019 Jun; 58():1-8. PubMed ID: 30711634 [TBL] [Abstract][Full Text] [Related]
22. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis. Liu B; Qiang L; Wang GD; Duan Q; Liu J Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103 [TBL] [Abstract][Full Text] [Related]
23. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway. Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506 [TBL] [Abstract][Full Text] [Related]
24. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy. Gao J; Wang W; Wang F; Guo C Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα. Lyu H; Li X; Wu Q; Hao L J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175 [TBL] [Abstract][Full Text] [Related]
26. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy. Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040 [TBL] [Abstract][Full Text] [Related]
27. m Liu P; Zhang B; Chen Z; He Y; Du Y; Liu Y; Chen X Aging (Albany NY); 2020 Mar; 12(6):5280-5299. PubMed ID: 32203053 [TBL] [Abstract][Full Text] [Related]
28. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN. Ai K; Zhu X; Kang Y; Li H; Zhang L Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease. Wang Y; Guo YF; Fu GP; Guan C; Zhang X; Yang DG; Shi YC Stem Cell Res Ther; 2020 Jul; 11(1):274. PubMed ID: 32641100 [TBL] [Abstract][Full Text] [Related]
30. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587 [TBL] [Abstract][Full Text] [Related]
31. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p. Fu JX; Sun GQ; Wang HL; Jiang HX J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962 [TBL] [Abstract][Full Text] [Related]
33. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy. Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702 [TBL] [Abstract][Full Text] [Related]
34. Regulation of connective tissue growth factor expression by miR-133b for the treatment of renal interstitial fibrosis in aged mice with unilateral ureteral obstruction. Cao D; Wang Y; Zhang Y; Zhang Y; Huang Q; Yin Z; Cai G; Chen X; Sun X Stem Cell Res Ther; 2021 Mar; 12(1):171. PubMed ID: 33691785 [TBL] [Abstract][Full Text] [Related]
35. EPA attenuates epithelial-mesenchymal transition and fibrosis through the TGF-β1/Smad3/ILK pathway in renal tubular epithelial HK-2 cells by up-regulating miR-541. Wei Z; Cao J; Zhang X; Yin D; Xu D; Lu G Int J Clin Exp Pathol; 2019; 12(7):2516-2525. PubMed ID: 31934078 [TBL] [Abstract][Full Text] [Related]
36. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649 [TBL] [Abstract][Full Text] [Related]
37. miR-185 affected the EMT, cell viability, and proliferation via DNMT1/MEG3 pathway in TGF-β1-induced renal fibrosis. Xue R; Li Y; Li X; Ma J; An C; Ma Z Cell Biol Int; 2019 Oct; 43(10):1152-1162. PubMed ID: 30095214 [TBL] [Abstract][Full Text] [Related]
38. miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells. Huang Y; Tong J; He F; Yu X; Fan L; Hu J; Tan J; Chen Z Int J Mol Med; 2015 Feb; 35(2):311-8. PubMed ID: 25421593 [TBL] [Abstract][Full Text] [Related]
39. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Zheng Z; Guan M; Jia Y; Wang D; Pang R; Lv F; Xiao Z; Wang L; Zhang H; Xue Y Sci Rep; 2016 Nov; 6():37492. PubMed ID: 27874055 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-98 inhibits TGF-β1-induced differentiation and collagen production of cardiac fibroblasts by targeting TGFBR1. Cheng R; Dang R; Zhou Y; Ding M; Hua H Hum Cell; 2017 Jul; 30(3):192-200. PubMed ID: 28251559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]